WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke VAXXAS wurde als Wortmarke am 20.04.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1536308 |
| Länder | 
|
| Basismarke |
Nr. 2041826,
04. Oktober 2019
|
| Anmeldedatum | 20. April 2020 |
| Ablaufdatum | 20. April 2030 |
Markeninhaber
c/- One Ventures Management,
Suite 13.02,
AU
Suite 13.02,
AU
Markenvertreter
Level 14, 255 Elizabeth Street
Sydney NSW 2000
AU
Waren und Dienstleistungen
05
Pharmaceutical, medicinal and therapeutic preparations for
human and veterinary use; vaccines; vaccine preparations;
diagnostic preparations for medical or veterinary purposes;
biological substances for human medical diagnostics and
analysis; transdermal patches, bandages, poultices and
dressings; patches, bandages, poultices and dressings
impregnated with vaccines; transdermal vaccine delivery
system being patches for administering vaccines;
pharmaceutical preparations contained in transdermal
patches; skin patches for the transdermal delivery of
pharmaceuticals; transdermal patches for administering
pharmaceuticals and vaccines; intradermal patches for
medical treatment; intradermal vaccine delivery system being
patches for administering vaccines; pharmaceutical
preparations contained in intradermal patches for medical
treatment; skin patches for the intradermal delivery of
pharmaceuticals; intradermal patches for medical treatment
for administering pharmaceuticals and vaccines;
micro-projection array patches for medical purposes; parts,
fittings and accessories for the aforesaid goods
10
Surgical and medical apparatus and instruments; drug
delivery devices and apparatus; drug delivery devices;
transdermal drug delivery devices and apparatus; intradermal
drug delivery devices and apparatus; micro-projection drug
delivery devices and apparatus; parts, fittings and
accessories for the aforesaid goods
40
Custom manufacturing services; custom manufacture of medical
devices, pharmaceuticals, diagnostic tests and testing kits;
custom manufacture of micro-projection array patches; custom
manufacture of drug delivery devices and apparatus; custom
manufacture of transdermal drug delivery devices and
apparatus; custom manufacture of intradermal drug delivery
devices and apparatus; custom manufacture of
micro-projection drug delivery devices and apparatus;
advisory, consultancy and information services in relation
to all of the aforesaid
42
Research, design and development services; medical research,
design and development services; research and development in
the pharmaceutical and biotechnology fields; research and
development of vaccines and medicines; drug discovery;
vaccine screening, namely safety testing of vaccines;
scientific and technological services; biological research,
clinical research and medical research; clinical trials;
providing medical and scientific research information in the
field of pharmaceuticals and clinical trials; chemical and
biochemical analysis services; medical and scientific
research; pharmaceutical research services; laboratory
testing services; laboratory research in the fields of
biotechnology, microbiology, molecular biology,
nanotechnology analytical chemistry, biochemistry, medicinal
chemistry and drug development; technology services;
scientific research, clinical research, development,
advisory and consultancy services in relation to antibody
production; research and development services in the field
of antibodies; antibody generation services being research
and development services; diagnostic and research services
and screening; diagnostic testing services; medical research
services; advisory services relating to diagnostic testing
of products for quality control and safety purposes;
research and development of products; advisory, consultancy
and information services in relation to all of the
aforesaid
44
Medical, clinical and healthcare services relating to
vaccines; medical and veterinary consultancy; medical
testing; advisory, consultancy and information services in
relation to all of the aforesaid
45
Exploitation and licensing of intellectual property and
technology; licensing of medical technology; licensing of
research and development; advisory, consultancy and
information services in relation to all of the aforesaid
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 03. Oktober 2022 | 2022/42 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 14. Februar 2022 | 2022/7 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 10. Dezember 2021 | 2021/50 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. November 2021 | 2021/47 Gaz | MX | Ablehnung |
| 09. November 2021 | 2021/45 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. Oktober 2021 | 2021/43 Gaz | CA | Ablehnung |
| 09. August 2021 | 2021/35 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Juli 2021 | 2021/26 Gaz | JP | Ablehnung |
| 21. Juni 2021 | 2021/25 Gaz | KR | Ablehnung |
| 18. Mai 2021 | 2021/20 Gaz | BR | Ablehnung |
| 10. Februar 2021 | 2021/7 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 28. Dezember 2020 | 2021/1 Gaz | IN | Ablehnung |
| 23. November 2020 | 2020/49 Gaz | EM | Ablehnung |
| 17. September 2020 | 2020/38 Gaz | GB | Ablehnung |
| 11. August 2020 | 2020/33 Gaz | US | Ablehnung |
| 20. April 2020 | 2020/23 Gaz | AU | Eintragung |
ID: 141536308